Goelzer Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,668
Closed -$268K 228
2022
Q1
$268K Sell
7,668
-386
-5% -$13.2K 0.02% 202
2021
Q4
$245K Sell
8,054
-416
-5% -$13.5K 0.02% 211
2021
Q3
$278K Sell
8,470
-6,416
-43% -$205K 0.02% 202
2021
Q2
$450K Buy
+14,886
New +$490K 0.04% 188

Other funds holding OGN

Goelzer Investment Management's OGN Position: Q2 2022 in Review

Goelzer Investment Management sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 7,668 shares — an estimated $268K sold.

Goelzer Investment Management first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $450K in Q2 2021. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Goelzer Investment Management reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Goelzer Investment Management sold 7,668 Organon & Co shares in Q2 2022, an estimated $268K.
  • Goelzer Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Goelzer Investment Management's Organon & Co position peaked at $450K in Q2 2021.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Goelzer Investment Management's 13F filing for Q2 2022, filed 1 Aug 2022.